Brain PET-MRI Systems Market Analysis

Phase (Clinical, Pre-clinical)

The pre-clinical segment in brain PET-MRI systems market is estimated to capture the largest revenue share of 54.3%, augmenting with a CAGR of 6.1% during the forecast period, i.e. 2025-2037. It is poised to hold USD 233.3 million in revenue by 2025, due to the increased demand for innovation in imaging diagnosis. This multimodality system combined the strength of PET and MRI, allowing the researchers to get a brain region-specific detailed analysis. Established research institutions such as the University of Manchester are also investing in acquiring hybrid imaging modalities to get high-quality anatomical illustrations. The rising scope of clinical research, facilitated by governing authorities is one of the positive influences impacting the market hike.

Product Type (Traditional Systems, Helium-free Systems)

With a revenue of USD 230.9 million, the traditional PET-MRI systems segment dominated the 2024 landscape. Further expanding with a CAGR of 6.2%, it is estimated to hold a brain PET-MRI systems market share of 57.7% by the forecast period. Better contrast among soft tissues and functional imaging capabilities has made it preferable to other imaging devices. Therefore, the segment is leading the market with an escalated amount of integration in the clinical and educational sectors. Alternatively, the enhanced operational efficiency and elimination of valuable elements as Helium, are captivating the focus of key market players such as Siemens Healthineers, and Philips Healthcare. Companies are aiming to bring innovative solutions in the production of helium-free brain PET-MRI systems, exhibiting a CAGR of 6.5%.

Our in-depth analysis of the global market includes the following segments: